Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry

Comparative short term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder

(2014) Jasmin Garg et al.   INDIAN PEDIATRICS

ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis

(2014) Guilherme V Polanczyk et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Managing the Risks of ADHD Treatments

(2014) Benjamin N. Schneider et al.   Current Psychiatry Reports

Practitioner Review: Current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents

(2013) Samuele Cortese et al.   JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY

Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta-analysis of atomoxetine and methylphenidate comparator clinical trials

(2013) Chris J Bushe et al.   Child and Adolescent Psychiatry and Mental Health

Safety of Attention-Deficit/Hyperactivity Disorder Medications in Children: An Intensive Pharmacosurveillance Monitoring Study

(2012) Simona Ruggiero et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Blood Pressure and Heart Rate Over 10 Years in the Multimodal Treatment Study of Children With ADHD

(2011) Benedetto Vitiello et al.   AMERICAN JOURNAL OF PSYCHIATRY

ADHD in adolescents with borderline personality disorder

(2011) Mario Speranza et al.   BMC Psychiatry

Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis

(2011) Raveen Hanwella et al.   BMC Psychiatry